Go to content

Renin-angiotensin system inhibitors and major cardiovascular events after sepsis

Share

Rationale — Adult sepsis survivors have an increased risk of experiencing long-term cardiovascular events.

Objective — To determine whether the cardiovascular risk following sepsis is mitigated by renin-angiotensin system inhibitors (RASi).

Methods — Population-based cohort study of adult sepsis survivors designed to emulate a target randomized trial with an active comparator and new-user design. We excluded patients with a first-line indication for prescription of RASi (e.g., coronary heart disease, heart failure, chronic kidney disease, and hypertension with diabetes mellitus). The main exposure of interest was a new prescription of a RASi within 30 days of hospital discharge. The active comparator was a new prescription of either a calcium channel blocker or a thiazide diuretic, also within 30 days of hospital discharge. The primary outcome of interest was the composite of myocardial infarction, stroke, and all-cause mortality during follow-up to 5 years. We used inverse probability weighting of a Cox proportional hazards model and reported results using hazards ratios (HR) with 95% confidence intervals (CI).

Results — The cohort included 7,174 adult sepsis survivors, of whom 3,805 were new users of a RASi and 3,369 were new users of a calcium channel blocker or a thiazide diuretic. New users of a RASi experienced a lower hazard of major cardiovascular events compared to new users of a calcium channel blocker or a thiazide diuretic (HR 0.93, 95% CI 0.87 – 0.99). This association was consistent across different follow-up intervals and multiple sensitivity analyses.

Conclusion — A new RASi prescription is associated with a reduction in major cardiovascular events after sepsis. A randomized controlled trial should be considered to confirm this finding.

Information

Citation

Angriman F, Rosella LC, Lawler PR, Ko DT, Martin CM, Wunsch H, Scales DC. Ann Am Thorac Soc. 2023; 20(3):414-23. Epub 2022 Oct 17.

View Source

Associated Sites